Otsuka Holdings Co Ltd is a leading pharmaceutical company in Japan and globally, dedicated to addressing intractable diseases and improving patient care through innovation and research.
Otsuka Holdings Co Ltd faces financial turbulence and uncertainty, but its innovative ultrasound renal denervation technology for high blood pressure holds promise for the company’s future.